共 37 条
[5]
Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2004, 44 (09)
:1792-1800
[10]
The boomers are coming: A total cost of care model of the impact of population aging on the cost of chronic conditions in the United States
[J].
DISEASE MANAGEMENT,
2007, 10 (02)
:51-60